Comments on "Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials".

IF 3.3 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Therapeutic Advances in Cardiovascular Disease Pub Date : 2026-01-01 Epub Date: 2026-05-21 DOI:10.1177/17539447261453501

Ankur Sharma, Varshini Vadhithala, Arun Kumar, Sushma Verma, Sushma Narsing Katkuri

引用次数: 0

查看原文本刊更多论文

RNA治疗遗传性转甲状腺蛋白淀粉样变性的神经学疗效和安全性：随机对照试验的系统评价和荟萃分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic Advances in Cardiovascular Disease CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

3.50

自引率

0.00%

发文量

审稿时长

9 weeks

期刊介绍： The journal is aimed at clinicians and researchers from the cardiovascular disease field and will be a forum for all views and reviews relating to this discipline.Topics covered will include: ·arteriosclerosis ·cardiomyopathies ·coronary artery disease ·diabetes ·heart failure ·hypertension ·metabolic syndrome ·obesity ·peripheral arterial disease ·stroke ·arrhythmias ·genetics